painomics: Making Pain Measurable. Independently funded. Contract-based Consulting. Leveraging multimodal pain, fatigue, cognition, activity, and sleep biomarker data for the purposes of: - Digital Twin + Continuous/Persistent/Portable Memory - Fibrograph - Graph dB - Predictive modelling - Autonomous Clinical Decision-Action Support Conditions of Interest: - Chronic non-cancer pain - Fibromyalgia Syndrome - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - Long COVID Data Inputs: - Unstructured Medical Records - ePROMs - Remote patient monitoring / wearables data - Vocal biomarkers - Clinical Laboratory & Imaging tests - Multi-omics (DNA, RNA, proteomics) - EEG / qEEG - Neurocognitive/neuropsych testing - Provocative physical testing - Quantitative sensory testing (QST) - Blood/Urine toxicology testing In support of: - Phase 3 & 4 Clinical Trials - Applied Chronic Pain Research - Pain Clinic 2.0 Redesigns - Controlled Drug Risk Mitigation strategies #painclinic #chronicpain #fibromyalgia #mecfs #datamodelling #painomics #multiomics #naturallanguageprocessing #llm #ai #predictiveanalytics #softwaredevelopment #cds
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2026
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was painomics founded?
painomics was founded in 2026.
What industry is painomics in?
painomics operates in Health and Human Services. Find similar Health and Human Services investors on gritt.io.